SIGLINDA FLORES: Open Payments
NPI 1396049375 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$168 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $168
Food & beverage: $168
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Janssen Biotech, Inc. | 1 | $26 |
| Incyte Corporation | 1 | $17 |
| BeOne Medicines USA, Inc. | 1 | $17 |
Products named: Enhertu, DATROWAY, DARZALEX, LYNPARZA, NIKTIMVO, TEVIMBRA.
Industry payments across FL — which companies pay providers there.
